Physician profile
Abby Walker
NPI 1760010755
$2,811.96
in general payments reported to CMS, 2019-2025
15 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $612 · 2022: $892 · 2023: $614 · 2024: $269 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,308.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $961.23 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Electromed, INC. | $484.44 | 2021-2025 | Smartvest |
| Astrazeneca Pharmaceuticals Lp | $425.03 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $274.32 | 2022-2025 | Dupixent |
| Advanced Respiratory, INC | $168.64 | 2021 | |
| Genzyme Corporation | $116.97 | 2022-2025 | |
| Medtronic, INC. | $99.88 | 2024-2025 | Pipeline, Solitaire X |
| Philips North America LLC | $70.38 | 2023-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Inspire Medical Systems, INC. | $49.97 | 2023-2024 | Inspire |
| Gilead Sciences, INC. | $42.65 | 2021 | |
| Jazz Pharmaceuticals INC. | $34.69 | 2022 | |
| Azurity Pharmaceuticals, INC. | $32.05 | 2025 | Alvesco |
| Alcresta Therapeutics, INC. | $18.74 | 2024 | Relizorb |
| Abbvie INC. | $17.34 | 2022 | |
| Glaxosmithkline, LLC. | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.